pharma Β· Acute Myeloid Leukemia Β· Narcolepsy Β· JAZZ
Jazz Pharmaceuticals Ireland
Jazz Pharmaceuticals Ireland Limited
Jazz Pharmaceuticals Ireland clinical programs β 208 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Waterloo Exchange, Waterloo Road, Dublin, 4, IE
- Founded
- 2003
- Employees
- 3,631
- Programs
- 208
- Drugs
- 91
- Patents
- 89
Jazz Pharmaceuticals Ireland projects
208 ClinicalTrials.gov programs sponsored by Jazz Pharmaceuticals Ireland.
Jazz Pharmaceuticals Ireland has 208 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Fludarabine
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia, Adult
1 trial -
Fludarabine
Jazz Pharmaceuticals Ireland Limited
Hematologic Malignancy
1 trial -
GWP42003
Jazz Pharmaceuticals Ireland Limited
Dyslipidemias
1 trial -
GWP42003-P
Jazz Pharmaceuticals Ireland Limited
Schizophrenia
1 trial -
GWP42003-P
Jazz Pharmaceuticals Ireland Limited
Autism Spectrum Disorder
1 trial -
GWP42003-P 5 mg/kg/day Dose
Jazz Pharmaceuticals Ireland Limited
Epilepsy
1 trial -
GWP42004
Jazz Pharmaceuticals Ireland Limited
Diabetes Mellitus, Type 2
1 trial -
GWP42006
Jazz Pharmaceuticals Ireland Limited
Autism Spectrum Disorder
1 trial -
GWP42006
Jazz Pharmaceuticals Ireland Limited
Epilepsy
2 trials -
Glasdegib
Jazz Pharmaceuticals Ireland Limited
Acute Myelogenous Leukemia (AML) Due to Therapy
1 trial -
JZP-110
Jazz Pharmaceuticals Ireland Limited
Excessive Sleepiness
1 trial -
JZP150
Jazz Pharmaceuticals Ireland Limited
Post Traumatic Stress Disorder
1 trial -
JZP3507
Jazz Pharmaceuticals Ireland Limited
Meningioma
1 trial -
JZP385
Jazz Pharmaceuticals Ireland Limited
Essential Tremor
1 trial -
JZP541
Jazz Pharmaceuticals Ireland Limited
Irritability Associated With Autism Spectrum Disorder
1 trial -
JZP598
Jazz Pharmaceuticals Ireland Limited
Patients with HER2-expressing solid tumors
1 trial -
Liposome-encapsulated Daunorubicin-Cytarabine
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia
2 trials -
Liposome-encapsulated Daunorubicin-Cytarabine
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
1 trial -
Liposome-encapsulated Daunorubicin-Cytarabine
Jazz Pharmaceuticals Ireland Limited
Essential Thrombocythemia
1 trial -
Lurbinectedin
Jazz Pharmaceuticals Ireland Limited
Advanced Soft-tissue Sarcoma
1 trial -
Lurbinectedin
Jazz Pharmaceuticals Ireland Limited
Small Cell Lung Cancer ( SCLC )
1 trial -
Lurbinectedin
Jazz Pharmaceuticals Ireland Limited
Refractory Ewing Sarcoma
1 trial -
Lurbinectedin
Jazz Pharmaceuticals Ireland Limited
Locally Advanced Soft Tissue Sarcoma
1 trial -
Lurbinectedin
Jazz Pharmaceuticals Ireland Limited
Extensive-stage Small-cell Lung Cancer
1 trial -
Lurbinectedin
Jazz Pharmaceuticals Ireland Limited
Ewing Sarcoma
1 trial -
Lurbinectedin
Jazz Pharmaceuticals Ireland Limited
Advanced Solid Tumor
1 trial -
Lurbinectedin 4 MG Injection [Zepzelca]
Jazz Pharmaceuticals Ireland Limited
Gastrointestinal Malignancies
1 trial -
Nabiximols
Jazz Pharmaceuticals Ireland Limited
NMO Spectrum Disorder
1 trial -
Nabiximols
Jazz Pharmaceuticals Ireland Limited
Glioblastoma
1 trial -
ONC201
Jazz Pharmaceuticals Ireland Limited
Diffuse Intrinsic Pontine Glioma
1 trial -
ONC201
Jazz Pharmaceuticals Ireland Limited
Multiple Myeloma
1 trial -
ONC201
Jazz Pharmaceuticals Ireland Limited
Advanced Glioblastoma
1 trial -
ONC201
Jazz Pharmaceuticals Ireland Limited
Meningioma
1 trial -
ONC206
Jazz Pharmaceuticals Ireland Limited
Advanced Pheochromocytoma and Paraganglioma
1 trial -
Open-Label
Jazz Pharmaceuticals Ireland Limited
Chronic Obstructive Pulmonary Disease
1 trial -
Paclitaxel
Jazz Pharmaceuticals Ireland Limited
Gastroesophageal Adenocarcinoma
1 trial -
Placebo
Jazz Pharmaceuticals Ireland Limited
Schizophrenia
1 trial -
Placebo
Jazz Pharmaceuticals Ireland Limited
Viruria
1 trial -
Placebo
Jazz Pharmaceuticals Ireland Limited
Parkinson Disease
1 trial -
Sativex
Jazz Pharmaceuticals Ireland Limited
Cancer
2 trials -
Sm-EDTMP
Jazz Pharmaceuticals Ireland Limited
Metastatic Osteosarcoma
1 trial -
Sodium Oxybate
Jazz Pharmaceuticals Ireland Limited
Alternating Hemiplegia of Childhood
1 trial -
Sodium Oxybate
Jazz Pharmaceuticals Ireland Limited
Essential Tremor
1 trial -
Sodium Oxybate
Jazz Pharmaceuticals Ireland Limited
Schizophrenia
1 trial -
Xyrem (sodium oxybate) oral solution
Jazz Pharmaceuticals Ireland Limited
Fibromyalgia
1 trial -
ZW25 (Zanidatamab)
Jazz Pharmaceuticals Ireland Limited
HER2+/HR+ Breast Cancer
1 trial -
ZW25 (Zanidatamab)
Jazz Pharmaceuticals Ireland Limited
HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
1 trial -
ZWI-ZW25-202
Jazz Pharmaceuticals Ireland Limited
Breast cancer patients including those with locally advanced (unresectable) or metastatic HER2-positive, HR-positive breast cancer
1 trial
Frequently asked questions
How many clinical projects does Jazz Pharmaceuticals Ireland have?
208 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.